pharmaceutical investing Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series
Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series Products That Provide Automated, Closed System Cellular Processing
Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017
Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development
